Back to Insulin research
insulin gip agonist cohort 2025-01-01 ClinicalTrials

Tirzepatide vs Semaglutide: Comparing Heart Outcomes in Type 2 Diabetes and Heart Failure

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Abstract

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction NCT ID: NCT06980623 Status: ACTIVE_NOT_RECRUITING Sponsor: Brigham and Women's Hospital Start:…

insulin semaglutide tirzepatide gip agonist glp 1 agonist gip-r
Source: clinicaltrials:NCT06980623 · Ingested 2026-04-03 · Digest: gemini-2.5-flash